Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology

María Luisa Pérez-Saldivar, Arturo Fajardo-Gutiérrez, Roberto Bernáldez-Ríos, Armando Martínez-Avalos, Aurora Medina-Sanson, Laura Espinosa-Hernández, José de Diego Flores-Chapa, Raquel Amador-Sánchez, José Gabriel Peñaloza-González, Francisco Javier Alvarez-Rodríguez, Victoria Bolea-Murga, Janet Flores-Lujano, María Del Carmen Rodríguez-Zepeda, Roberto Rivera-Luna, Elisa María Dorantes-Acosta, Elva Jiménez-Hernández, Martha Alvarado-Ibarra, Martha Margarita Velázquez-Aviña, José Refugio Torres-Nava, David Aldebarán Duarte-Rodríguez, Rogelio Paredes-Aguilera, María de Los Ángeles Del Campo-Martínez, Rocío Cárdenas-Cardos, Paola Hillary Alamilla-Galicia, Vilma Carolina Bekker-Méndez, Manuel Carlos Ortega-Alvarez, Juan Manuel Mejia-Arangure, María Luisa Pérez-Saldivar, Arturo Fajardo-Gutiérrez, Roberto Bernáldez-Ríos, Armando Martínez-Avalos, Aurora Medina-Sanson, Laura Espinosa-Hernández, José de Diego Flores-Chapa, Raquel Amador-Sánchez, José Gabriel Peñaloza-González, Francisco Javier Alvarez-Rodríguez, Victoria Bolea-Murga, Janet Flores-Lujano, María Del Carmen Rodríguez-Zepeda, Roberto Rivera-Luna, Elisa María Dorantes-Acosta, Elva Jiménez-Hernández, Martha Alvarado-Ibarra, Martha Margarita Velázquez-Aviña, José Refugio Torres-Nava, David Aldebarán Duarte-Rodríguez, Rogelio Paredes-Aguilera, María de Los Ángeles Del Campo-Martínez, Rocío Cárdenas-Cardos, Paola Hillary Alamilla-Galicia, Vilma Carolina Bekker-Méndez, Manuel Carlos Ortega-Alvarez, Juan Manuel Mejia-Arangure

Abstract

Background: Worldwide, acute leukemia is the most common type of childhood cancer. It is particularly common in the Hispanic populations residing in the United States, Costa Rica, and Mexico City. The objective of this study was to determine the incidence of acute leukemia in children who were diagnosed and treated in public hospitals in Mexico City.

Methods: Included in this study were those children, under 15 years of age and residents of Mexico City, who were diagnosed in 2006 and 2007 with leukemia, as determined by using the International Classification of Childhood Cancer. The average annual incidence rates (AAIR), and the standardized average annual incidence rates (SAAIR) per million children were calculated. We calculated crude, age- and sex-specific incidence rates and adjusted for age by the direct method with the world population as standard. We determined if there were a correlation between the incidence of acute leukemias in the various boroughs of Mexico City and either the number of agricultural hectares, the average number of persons per household, or the municipal human development index for Mexico (used as a reference of socio-economic level).

Results: Although a total of 610 new cases of leukemia were registered during 2006-2007, only 228 fit the criteria for inclusion in this study. The overall SAAIR was 57.6 per million children (95% CI, 46.9-68.3); acute lymphoblastic leukemia (ALL) was the most frequent type of leukemia, constituting 85.1% of the cases (SAAIR: 49.5 per million), followed by acute myeloblastic leukemia at 12.3% (SAAIR: 6.9 per million), and chronic myeloid leukemia at 1.7% (SAAIR: 0.9 per million). The 1-4 years age group had the highest SAAIR for ALL (77.7 per million). For cases of ALL, 73.2% had precursor B-cell immunophenotype (SAAIR: 35.8 per million) and 12.4% had T-cell immunophenotype (SAAIR 6.3 per million). The peak ages for ALL were 2-6 years and 8-10 years. More than half the children (58.8%) were classified as high risk. There was a positive correlation between the average number of persons per household and the incidence of the pre-B immunophenotype (Pearson's r, 0.789; P = 0.02).

Conclusions: The frequency of ALL in Mexico City is among the highest in the world, similar to those found for Hispanics in the United States and in Costa Rica.

Figures

Figure 1
Figure 1
Comparison of age-specific incidence rates of childhood leukemia in Mexico City (2006-2007). The age-specific incidence rates of acute lymphoid leukemia (ALL), of acute myeloid leukemia (AML), and of ALL immunophenotypes (precursor B-cell, T cell, and B cell) for Mexico City children (2006-2007) were compared.
Figure 2
Figure 2
Correlations between municipal human development indices of boroughs of Mexico City and incidences of ALL and of precursor B-cell immunophenotype. Panel A: Incidence of ALL; Panel B: Incidence of precursor B-cell immunophenotype. SAAIR: standardized average annual incidence rate by million of children below under 15 years of age; MHDI: municipal human development index; Boroughs of Mexico City: 1) Álvaro Obregón; 2) Azcapotzalco; 3) Benito Juárez; 4) Coyoacán; 5) Cuajimalpa de Morelos; 6) Cuauhtémoc; 7) Gustavo A. Madero; 8) Iztacalco; 9) Iztapalapa; 10) La Magdalena Contreras; 11) Miguel Hidalgo; 12) Milpa Alta; 13) Tláhuac; and 14) Tlalpan; 15) Venustiano Carranza; and 16) Xochimilco. Source: Municipal Human Development Index (MHDI) for Mexico 2005 [18]. *Expressed per million children.

References

    1. Wilkinson JD, Gonzalez A, Wohler-Torres B, Fleming LE, MacKinnon J, Trapido E, Button J, Peace S. Cancer incidence among Hispanic children in the United States. Rev Panam Salud Publica. 2005;18:5–13. doi: 10.1590/S1020-49892005000600002.
    1. American Cancer Society. Cancer in children and adolescents. Cancer acts & Figures for Hispanics/Latinos 2009-2011.
    1. Matasar MJ, Ritchie EK, Consedine N, Magai C, Neugut AI. Incidence rates of the major leukemia subtypes among US Hispanics, Blacks, and non-Hispanic Whites. Leuk Lymphoma. 2006;47:2365–2370. doi: 10.1080/10428190600799888.
    1. Parkin DW, Stiller CA. Childhood cancer in developing countries: environmental factors. Int J Pediatr Hematol Oncol. 1995;2:411–417.
    1. Monge P, Wesseling C, Rodríguez AC, Cantor KP, Weiderpass E, Reutfors J, Ahlbom A, Partanen T. Childhood leukaemia in Costa Rica, 1981-96. Paediatr Perinat Epidemiol. 2002;16:210–218. doi: 10.1046/j.1365-3016.2002.00422.x.
    1. Mejía-Aranguré JM, Bonilla M, Lorenzana R, Juárez-Ocaña S, de Reyes G, Pérez-Saldivar ML, González-Miranda G, Bernáldez-Ríos R, Ortiz-Fernández A, Ortega-Alvarez M, Martínez-García M del C, Fajardo-Gutiérrez A. Incidence of leukemias in children from El Salvador and Mexico City between 1996 and 2000: population-based data. BMC Cancer. 2005;5:33. doi: 10.1186/1471-2407-5-33.
    1. Fajardo-Gutiérrez A, Juárez-Ocaña S, González-Miranda G, Palma-Padilla V, Carreón-Cruz R, Ortega-Alvárez MC, Mejía-Arangure JM. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the Cancer registry (a population-based study) BMC Cancer. 2007;7:68. doi: 10.1186/1471-2407-7-68.
    1. Bernaldez-Rios R, Ortega-Alvarez MC, Perez-Saldivar ML, Alatoma-Medina NE, Del Campo-Martinez M de L, Rodriguez-Zepeda M del C, Montero-Ponce I, Franco-Ornelas S, Fernandez-Castillo G, Nuñez-Villegas NN, Taboada-Flores MA, Flores-Lujano J, Argüelles-Sanchez ME, Juarez-Ocaña S, Fajardo-Gutierrez A, Mejia-Arangure JM. The age incidence of childhood B-cell precursor acute lymphoblastic leukemia in Mexico City. J Pediatr Hematol Oncol. 2008;30:199–203. doi: 10.1097/MPH.0b013e318162bcdc.
    1. Mejía-Arangure JM, Fajardo-Gutiérrez A, Bernáldez-Ríos R, Rodríguez-Zepeda MC, Espinoza-Hernández L, Martínez-García MC. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy. Arch Med Res. 1997;28:273–279.
    1. Fajardo-Gutiérrez A, Sandoval-Mex AM, Mejía-Aranguré JM, Rendón-Macías ME, Martínez-Garía MC. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol. 2002;39:25–31. doi: 10.1002/mpo.10100.
    1. Frenk J, González-Pier E, Gómez-Dantés O, Lezana MA, Knaul FM. Comprehensive reform to improve health system performance in Mexico. Lancet. 2006;368:1524–1534. doi: 10.1016/S0140-6736(06)69564-0.
    1. Mejía-Aranguré JM, Fajardo-Gutiérrez A, Bernáldez-Ríos R, Farfán-Canto JM, Ortíz-Fernández A, Martínez-García MD. Incidence trends of acute leukemia among the children of Mexico City: 1982-1991. Arch Med Res. 1996;27:223–227.
    1. Flores-Lujano J, Perez-Saldivar ML, Fuentes-Pananá EM, Gorodezky C, Bernaldez-Rios R, Del Campo-Martinez MA, Martinez-Avalos A, Medina-Sanson A, Paredes-Aguilera R, De Diego-Flores Chapa J, Bolea-Murga V, Rodriguez-Zepeda MC, Rivera-Luna R, Palomo-Colli MA, Romero-Guzman L, Perez-Vera P, Alvarado-Ibarra M, Salamanca-Gómez F, Fajardo-Gutierrez A, Mejía-Aranguré JM. Breastfeeding and early infection in the aetiology of childhood leukaemia in Down syndrome. Br J Cancer. 2009;101:860–864. doi: 10.1038/sj.bjc.6605244.
    1. Kramárová E, Stiller CA. The international classification of childhood cancer. Int J Cancer. 1996;68:759–765. doi: 10.1002/(SICI)1097-0215(19961211)68:6<759::AID-IJC12>;2-W. Review.
    1. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030–1043. doi: 10.1016/S0140-6736(08)60457-2.
    1. Instituto Nacional de Estadística y Geografía (INEGI) II Conteo de Población y vivienda 2005.
    1. Smith PG. In: Cancer incidence in five continents. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, editor. Vol. 6. Lyon: IARC. Scientific Publication No. 120; 1992. Comparison between registries: age-standardized rates; pp. 865–870.
    1. Índice de Desarrollo Humano Municipal en México 2005. Programa de las Naciones Unidas para el Desarrollo. Accessed on 9 November 2010.
    1. Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull. 1996;52:682–703.
    1. Poole C, Greenland S, Luetters C, Kelsey JL, Mezei G. Socioeconomic status and childhood leukaemia: a review. Int J Epidemiol. 2006;35:370–384.
    1. Parkin DM, Kramárová E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller C. International incidence of childhood cancer. II. IARC Scientific Publication No. 144. Lyon: IARC; 1998.
    1. Wilkinson JD, Fleming LE, MacKinnon J, Voti L, Wohler-Torres B, Peace S, Trapido E. Lymphoma and lymphoid leukemia incidence in Florida children: Ethnic and racial distribution. Cancer. 2001;91:1402–1408. doi: 10.1002/1097-0142(20010401)91:7<1402::AID-CNCR1145>;2-6.
    1. Glazer ER, Perkins CI, Young JL Jr, Schlag RD, Campleman SL, Wright WE. Cancer among Hispanic children in California, 1988-1994: comparison with non-Hispanic white children. Cancer. 1999;86:1070–1079. doi: 10.1002/(SICI)1097-0142(19990915)86:6<1070::AID-CNCR25>;2-9.
    1. Texas Department of State Health Services. Cancer Epidemiology and Surveillance Branch, Texas Cancer Registry.
    1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute. Bethesda, MD;
    1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute;
    1. Drut R, Hernández A, Pollono D. Incidence of childhood cancer in La Plata, Argentina, 1977-1987. Int J Cancer. 1990;45:1045–1047. doi: 10.1002/ijc.2910450611.
    1. de Camargo B, de Oliveira Santos M, Rebelo MS, de Souza Reis R, Ferman S, Noronha CP, Pombo-de-Oliveira MS. Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer. 2010;126:715–720. doi: 10.1002/ijc.24799.
    1. Schenker MB. A global perspective of migration and occupational health. Am J Ind Med. 2010;53:329–337. doi: 10.1002/ajim.20834.
    1. Perez-Saldivar ML, Ortega-Alvarez MC, Fajardo-Gutierrez A, Bernaldez-Rios R, Del Campo-Martinez M de L, Medina-Sanson A, Palomo-Colli MA, Paredes-Aguilera R, Martínez-Avalos A, Borja-Aburto VH, Rodriguez-Rivera M de J, Vargas-Garcia VM, Zarco-Contreras J, Flores-Lujano J, Mejia-Arangure JM. Father's occupational exposure to carcinogenic agents and childhood acute leukemia: a new method to assess exposure (a case-control study) BMC Cancer. 2008;8:7. doi: 10.1186/1471-2407-8-7.
    1. Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk BI, Howard SC, Hudson MM, Cheng C, Kun LE, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE. Total Therapy Study XIIIB at St Jude Children's Research Hospital. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood. 2004;104:2690–2696. doi: 10.1182/blood-2004-04-1616.
    1. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Bravo-Lindoro A, Correa-González C, Joly-Linero R, Nieto-Martínez S, del Campo-Martínez A. Immunophenotyping of acute lymphoblastic leukemia in Mexican children. Sangre (Barc) 1999;44:188–194. [Article in Spanish]
    1. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Burbano-Ceron L, Camacho-Del Monte O, Nieto-Martinez S. Flow cytometric analysis of cell-surface and intracelular antigens in the diagnosis of acute leukemia. Am J Hematol. 2001;68:69–74. doi: 10.1002/ajh.1155.
    1. Bhojwani D, Howard SC, Pui CH. High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009;9(Suppl 3):S222–230. Review.
    1. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med. 1993;329:1289–1295. doi: 10.1056/NEJM199310283291801.
    1. Mejía-Arangure JM, Fajardo-Gutiérrez A, Bernáldez-Ríos R, Rodríguez-Zepeda MC, Espinoza-Hernández L, Martínez-García MC. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy. Arch Med Res. 1997;28:273–279.
    1. Schmiegelow K, Vestergaard T, Nielsen SM, Hjalgrim H. Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis. Leukemia. 2008;22:2137–2141. doi: 10.1038/leu.2008.212.
    1. Daniel-Cravioto A, Gonzalez-Bonilla CR, Mejia-Arangure JM, Perez-Saldivar ML, Fajardo-Gutierrez A, Jimenez-Hernandez E, Hernandez-Serrano M, Bekker-Mendez VC. Genetic rearrangement MLL/AF4 is most frequent in children with acute lymphoblastic leukemias in Mexico City. Leuk Lymphoma. 2009;50:1352–1360. doi: 10.1080/10428190903015636.
    1. Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, Felix CA, Davies SM, Slavin J, Potter JD, Blair CK, Reaman GH, Ross JA. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev. 2005;14:651–655. doi: 10.1158/1055-9965.EPI-04-0602.
    1. Rodríguez L, González-Llano O, Mancias C, Pompa T, González G, Sandoval A, Palafox MT, Támez L, Tovar C, Gómez-Almaguer D. Observaciones sobre la incidencia de leucemias agudas en el Noreste de México. Rev Hematol Mex. 2010;11:78–81.
    1. de Souza Reis R Sr, de Camargo B, de Oliveira Santos M, de Oliveira JM, Azevedo Silva F, Pombo-de-Oliveira MS. Childhood leukemia incidence in Brazil according to different geographical regions. Pediatr Blood & Cancer. 2011;56:58–64. doi: 10.1002/pbc.22736.

Source: PubMed

3
Abonner